CD226 and cancer: Blocking DNAM-1 resulted in the decrease of % of 7-AAD+ THP-1 cells and MFI of these cells, while blocking NKG2D led to the decrease in MFI (Fig 6C and 6D), suggesting that both molecules are involved in cancer recognition.